Hancock Jaffe Laboratories, Inc. Made Big Gain

Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ) shot up at $0.56, a gain of 37.5%. The stock appeared on our News Catalysts scanner on Fri 21 Aug 20 at 09:09 AM in the 'BIOTECH' category. From Thu 27 Aug 20, the stock recorded 22.22% Up Days and 40.00% Green Days
The stock spiked on Fri 21 Aug 20 at $0.81 with a volume of 465M+, and its share price has been moving sideways in recent weeks.
About Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ)
Hancock Jaffe Laboratories Inc development stage medical device company. It develops and sells biological tissue solutions to treat patients with coronary, vascular, end stage renal and peripheral arterial diseases in the United States and Europe.
Top 10 Gainers:
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 37.51%
- Salem Media Group, Inc. (SALM:NASDAQ), 35.57%
- NNOX (NNOX:NASDAQ), 32.87%
- LTRN (LTRN:NASDAQ), 27.84%
- A-Mark Precious Metals, Inc. (AMRK:NASDAQ), 27.21%
- Cinedigm Corp. (CIDM:NASDAQ), 27.09%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 22.75%
- Natural Health Trends Corp. (NHTC:NASDAQ), 21.6%
- Biofrontera AG (BFRA:NASDAQ), 18.97%
- Teligent, Inc. (TLGT:NASDAQ), 18.8%